Healthy Skepticism Library item: 6622

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Barnett AA.
FDA warns Pfizer on sertraline marketing
Lancet 1996; 348:469

Abstract:

The Food and Drug Administration has warned Pfizer about making unsubstantiated claims about its antidepressant sertraline (Zoloft) and will require Pfizer to send out a “Dear Doctor” letter.

Keywords:
*news story/United States/FDA/Food and Drug Administration/Pfizer/regulation of promotion/quality of information/EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION/REGULATION, CODES, GUIDELINES: COMPLIANCE, SANCTIONS, STANDARDS/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION